These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4410147)

  • 21. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig.
    Garcia-Contreras L; Sethuraman V; Kazantseva M; Godfrey V; Hickey AJ
    J Antimicrob Chemother; 2006 Nov; 58(5):980-6. PubMed ID: 16971416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The liver and rifampicin].
    Piéron R; Marien C; Jagueux M
    Cah Med; 1973 Jun; 14(6):447-51. PubMed ID: 4766668
    [No Abstract]   [Full Text] [Related]  

  • 24. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection.
    Ijaz K; McElroy PD; Jereb J; Navin TR; Castro KG
    Clin Infect Dis; 2007 Feb; 44(3):464-5; author reply 465. PubMed ID: 17205462
    [No Abstract]   [Full Text] [Related]  

  • 26. [Adverse effects of rifampicin].
    Fontagne J
    Therapie; 1973; 28(1):181-5. PubMed ID: 4731481
    [No Abstract]   [Full Text] [Related]  

  • 27. [Morphological changes in the liver of guinea pigs with minor tubercular changes treated for a prolonged period with streptomycin, phthivazid and PASK].
    Rudaĭtene AP
    Probl Tuberk; 1970; 48(4):78-82. PubMed ID: 5528471
    [No Abstract]   [Full Text] [Related]  

  • 28. Intermittent rifampicin treatment in experimental tuberculosis.
    Algeorge G; Rudescu D; Petre A
    Arch Roum Pathol Exp Microbiol; 1973 Jun; 32(2):277-86. PubMed ID: 4584318
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of rifampicin on the nonspecific reactivity and natural resistence to tuberculosis in guinea pigs].
    Shiniberov VA
    Probl Tuberk; 1979 Jan; (1):50-4. PubMed ID: 419108
    [No Abstract]   [Full Text] [Related]  

  • 30. [Light and electron microscopy studies of the liver in tuberculosis patients receiving rifampin and isoniazid].
    Pilheu JA; de Salvo MC; Koch O; Barcat JA
    Medicina (B Aires); 1981; 41(4):439-45. PubMed ID: 7339434
    [No Abstract]   [Full Text] [Related]  

  • 31. Experiences with rifampicin.
    Mary Aquinas Sister
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():137-9. PubMed ID: 4467982
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antifibrotic action of sodium succinate in experimental tuberculosis].
    Suslov EI; Maliuk VI; Korzhov VI; Gunzburg TS
    Probl Tuberk; 1980 Feb; (2):57-9. PubMed ID: 7375465
    [No Abstract]   [Full Text] [Related]  

  • 33. [Icterus and rifampicin].
    Piéron R; Marien C; Kaufmann JP; Jageux M; Botero M
    Ann Med Interne (Paris); 1971; 122(8):889-96. PubMed ID: 5124364
    [No Abstract]   [Full Text] [Related]  

  • 34. Experiences with rifampicin.
    Aquinas M
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():272-5. PubMed ID: 4468021
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rifampicin and liver function (72 punctures biopsies)].
    Taranger J; Girbal JP; Giacchero G
    Rev Tuberc Pneumol (Paris); 1970; 34(5):717-20. PubMed ID: 5496796
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antitubercular activity and pharmacokinetics of rifampicin].
    Ginzburg TS; Drabkina RO
    Antibiotiki; 1972 Jul; 17(7):607-11. PubMed ID: 4655011
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental study of the effect of rifampicin on antituberculosis immunity].
    Chernushenko EF; Shiniberov VA
    Probl Tuberk; 1983 Feb; (2):47-51. PubMed ID: 6601802
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatic tolerance in man of rifampicin-isoniazid association].
    Toulet J; Plomteux G; Viteau JM; Abiven M; Bonfante N
    J Med Liban; 1971; 24(6):651-8. PubMed ID: 5146848
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intermittent rifomycin therapy of experimental tuberculosis in guinea pigs].
    Daddi G; Lucchesi M; Mancini P
    Ann Ist Carlo Forlanini; 1968; 28(4):354-68. PubMed ID: 5738472
    [No Abstract]   [Full Text] [Related]  

  • 40. [Disturbance of liver function caused by postoperative administration of rifampicin and-or ethionamide from standpoint of surgical treatment for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1974 Jul; 49(7):201-6. PubMed ID: 4431109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.